Inveresk Research Group, Inc. Files Shelf Registration Statement With the Securities and Exchange Commission
09 Março 2004 - 2:09PM
PR Newswire (US)
Inveresk Research Group, Inc. Files Shelf Registration Statement
With the Securities and Exchange Commission CARY, N.C., March 9
/PRNewswire-FirstCall/ -- Inveresk Research Group, Inc. today
announced the filing of a registration statement with theSecurities
and Exchange Commission covering the re-sale of an aggregate of up
to 8,669,714 shares of common stock. All of the shares covered by
the registration statement are owned by the selling stockholders
named in the filing. None of the shares covered by the registration
statement will be sold for the account of Inveresk Research Group,
Inc. The registration statement on Form S-3 has been filed with the
Securities and Exchange Commission but has not yet become
effective. These shares may notbe sold nor may offers to buy be
accepted prior to the time the registration statement becomes
effective. This press release shall not constitute an offer to sell
or the solicitation of an offer to buy nor shall there be any sale
of these shares in any state in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under
the securities laws of any such state. Inveresk is the leading
provider of drug development services to companies in the
pharmaceutical andbiotechnology industries. The company is based in
Cary, North Carolina with major facilities also in Edinburgh,
Scotland and Montreal, Canada. DATASOURCE: Inveresk Research Group,
Inc. CONTACT: Matt Dallas for Inveresk Research Group, Inc.,
+1-212-850-5627
Copyright
Inveresk (NASDAQ:IRGI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Inveresk (NASDAQ:IRGI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Inveresk Research Grp. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Inveresk Research Grp. (MM)